SKI Market

Indian Indices

Sensex

82,225.92 -1,068.74
( -1.28%)

Global Indices

Nasdaq

49,202.49 377.42
(0.77%)

Dow Jones

6,910.52 51.77
(0.75%)

Hang Seng

57,337.44 511.74
(0.90%)

Nikkei 225

10,686.70 1.96
(0.02%)

Forex

USD-INR

90.87 0.15
(0.16%)

EUR-INR

107.26 0.37
(0.35%)

GBP-INR

122.73 0.47
(0.39%)

JPY-INR

0.59 0.00
(0.51%)

YOU ARE HERE :
HOME
Markets
Equity
Company News

EQUITY - MARKET SCREENER

Cipla Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500087

INE059A01026

411.5552288

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CIPLA

23.38

107135.95

EPS(TTM)

Face Value()

Div & Yield %

56.72

1.21

Date	Headline
23-Jan-2026	Cipla consolidated net profit declines 56.97% in the December 2025 quarter
23-Jan-2026	Cipla slides as Q3 PAT tanks 57% YoY to Rs 676 crore
19-Jan-2026	Cipla Ltd slips for fifth straight session
07-Jan-2026	Cipla Ltd leads losers in 'A' group
24-Dec-2025	Cipla declare Quarterly Result
19-Dec-2025	Pfizer signs supply and marketing agreement with Cipla
10-Dec-2025	Cipla receives ESG rating of 66
13-Nov-2025	Cipla Ltd spurts 0.37%, gains for fifth straight session
03-Nov-2025	Cipla Ltd - Cipla Limited - Analysts/Institutional Investor Meet/Con. Call Updates
03-Nov-2025	Cipla Ltd - Cipla Limited - Acquisition

<< < 1 2 3 ... > >>

82,225.92 -1,068.74 ( -1.28%)

49,202.49 377.42 (0.77%)

6,910.52 51.77 (0.75%)

57,337.44 511.74 (0.90%)

10,686.70 1.96 (0.02%)

90.87 0.15 (0.16%)

107.26 0.37 (0.35%)

122.73 0.47 (0.39%)

0.59 0.00 (0.51%)